These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33992954)

  • 1. Plausible drug interaction between cyclophosphamide and voriconazole via inhibition of CYP2B6.
    Shibata Y; Tamemoto Y; Singh SP; Yoshitomo A; Hozuki S; Sato H; Hisaka A
    Drug Metab Pharmacokinet; 2021 Aug; 39():100396. PubMed ID: 33992954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 Oxidoreductase Influences CYP2B6 Activity in Cyclophosphamide Bioactivation.
    El-Serafi I; Afsharian P; Moshfegh A; Hassan M; Terelius Y
    PLoS One; 2015; 10(11):e0141979. PubMed ID: 26544874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Study Design Using Continuous Intravenous and Intraduodenal Infusions of Midazolam and Voriconazole for Mechanistic Quantitative Assessment of Hepatic and Intestinal CYP3A Inhibition.
    Li X; Junge L; Taubert M; von Georg A; Dahlinger D; Starke C; Frechen S; Stelzer C; Kinzig M; Sörgel F; Jaehde U; Töx U; Goeser T; Fuhr U
    J Clin Pharmacol; 2020 Sep; 60(9):1237-1253. PubMed ID: 32427354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NADPH-Independent Inactivation of CYP2B6 and NADPH-Dependent Inactivation of CYP3A4/5 by PBD: Potential Implication for Assessing Covalent Modulators for Time-Dependent Inhibition.
    Kosaka M; Zhang D; Wong S; Yan Z
    Drug Metab Dispos; 2020 Aug; 48(8):655-661. PubMed ID: 32482757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of In Vitro Cytochrome P450 Inhibition and In Vitro Fate of Structurally Diverse N-Oxide Metabolites: Case Studies with Clozapine, Levofloxacin, Roflumilast, Voriconazole and Zopiclone.
    Giri P; Naidu S; Patel N; Patel H; Srinivas NR
    Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):677-688. PubMed ID: 27853934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive in vitro analysis of voriconazole inhibition of eight cytochrome P450 (CYP) enzymes: major effect on CYPs 2B6, 2C9, 2C19, and 3A.
    Jeong S; Nguyen PD; Desta Z
    Antimicrob Agents Chemother; 2009 Feb; 53(2):541-51. PubMed ID: 19029318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantioselective inhibition of Cytochrome P450-mediated drug metabolism by a novel antithrombotic agent, S002-333: Major effect on CYP2B6.
    Bhateria M; Ramakrishna R; Puttrevu SK; Saxena AK; Bhatta RS
    Chem Biol Interact; 2016 Aug; 256():257-65. PubMed ID: 27387538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Cytochrome P450 2B6 Activity by Voriconazole Profiled Using Efavirenz Disposition in Healthy Volunteers.
    Desta Z; Metzger IF; Thong N; Lu JB; Callaghan JT; Skaar TC; Flockhart DA; Galinsky RE
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6813-6822. PubMed ID: 27600044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Drug-Induced Liver Injury in HepG2 Cells Cultured with Human Liver Microsomes.
    Choi JM; Oh SJ; Lee JY; Jeon JS; Ryu CS; Kim YM; Lee K; Kim SK
    Chem Res Toxicol; 2015 May; 28(5):872-85. PubMed ID: 25860621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent inhibition of cytochrome P450 2B6 by sibutramine in human liver microsomes.
    Bae SH; Kwon MJ; Choi EJ; Zheng YF; Yoon KD; Liu KH; Bae SK
    Chem Biol Interact; 2013 Sep; 205(1):11-9. PubMed ID: 23777987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of CYP2B6, 3A4 and β-esterase interactions of Withania somnifera (L.) dunal in human liver microsomes and HepG2 cells.
    Kumar S; Bouic PJ; Rosenkranz B
    J Ethnopharmacol; 2021 Apr; 270():113766. PubMed ID: 33395575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling Method.
    Bosilkovska M; Samer C; Déglon J; Thomas A; Walder B; Desmeules J; Daali Y
    Basic Clin Pharmacol Toxicol; 2016 Sep; 119(3):284-90. PubMed ID: 27009433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between CYP2B6 genetic variability and cyclophosphamide therapy in pediatric patients with neuroblastoma.
    Mangó K; Fekete F; Kiss ÁF; Erdős R; Fekete JT; Bűdi T; Bruckner E; Garami M; Micsik T; Monostory K
    Sci Rep; 2023 Jul; 13(1):11770. PubMed ID: 37479763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme Kinetics and Molecular Docking Studies on Cytochrome 2B6, 2C19, 2E1, and 3A4 Activities by Sauchinone.
    Gong EC; Chea S; Balupuri A; Kang NS; Chin YW; Choi YH
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29498658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of human liver microsomal CYP3A4 and CYP2B6 in catalyzing N-dechloroethylation of cyclophosphamide and ifosfamide.
    Huang Z; Roy P; Waxman DJ
    Biochem Pharmacol; 2000 Apr; 59(8):961-72. PubMed ID: 10692561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes.
    Misaka S; Kawabe K; Onoue S; Werba JP; Giroli M; Tamaki S; Kan T; Kimura J; Watanabe H; Yamada S
    Drug Metab Pharmacokinet; 2013; 28(3):244-9. PubMed ID: 23268924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triethylenethiophosphoramide is a specific inhibitor of cytochrome P450 2B6: implications for cyclophosphamide metabolism.
    Rae JM; Soukhova NV; Flockhart DA; Desta Z
    Drug Metab Dispos; 2002 May; 30(5):525-30. PubMed ID: 11950782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A semiphysiological population pharmacokinetic model for dynamic inhibition of liver and gut wall cytochrome P450 3A by voriconazole.
    Frechen S; Junge L; Saari TI; Suleiman AA; Rokitta D; Neuvonen PJ; Olkkola KT; Fuhr U
    Clin Pharmacokinet; 2013 Sep; 52(9):763-81. PubMed ID: 23653047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of metabolism dependent inhibition of CYP2B6 mediated bupropion hydroxylation in human liver microsomes by monoamine oxidase inhibitors and prediction of potential as perpetrators of drug interaction.
    Nirogi R; Palacharla RC; Mohammed AR; Manoharan A; Ponnamaneni RK; Bhyrapuneni G
    Chem Biol Interact; 2015 Mar; 230():9-20. PubMed ID: 25656918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibitory effects of machilin A isolated from Machilus thunbergii on human cytochrome P450 1A and 2B6.
    Kim SJ; You J; Choi HG; Kim JA; Jee JG; Lee S
    Phytomedicine; 2015 Jun; 22(6):615-20. PubMed ID: 26055126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.